Clinical Trial for the Investigational Drug (PB-201) in Subjects With Type 2 Diabetes Mellitus

NCT03973515 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Type2 Diabetes Mellitus

Interventions

DRUG: glucokinase activator
DRUG: Placebo

Sponsor

PegBio Co., Ltd.